Synergistic Antiviral Activity of Pamapimod and Pioglitazone against SARS-CoV-2 and Its Variants of Concern

The SARS-CoV-2 pandemic remains a major public health threat, especially due to newly emerging SARS-CoV-2 Variants of Concern (VoCs), which are more efficiently transmitted, more virulent, and more able to escape naturally acquired and vaccine-induced immunity. Recently, the protease inhibitor Paxlo...

Descripción completa

Detalles Bibliográficos
Autores principales: Setz, Christian, Große, Maximilian, Auth, Janina, Fröba, Maria, Rauch, Pia, Bausch, Alexander, Wright, Matthew, Schubert, Ulrich
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224751/
https://www.ncbi.nlm.nih.gov/pubmed/35743273
http://dx.doi.org/10.3390/ijms23126830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9224751/
https://www.ncbi.nlm.nih.gov/pubmed/35743273
http://dx.doi.org/10.3390/ijms23126830

Ejemplares similares